Menopause is a term used to describe the permanent cessation of the primary functions of the human ovaries: the ripening and release of ova and the release of hormones that cause both the creation of the uterine lining and the subsequent shedding of the uterine lining (a.k.a. the menses or the period). Menopause typically occurs in women in midlife, during their late 40s or early 50s.  For some women, the accompanying signs and effects that can occur during the menopause transition years can significantly disrupt their daily activities and sense of well-being. 
  • Women undertaking post-menopausal hormone therapy are at a higher risk for ovarian cancer, a study by the European Prospective Investigation into Cancer and Nutrition said.
  • Menerba, a new drug to cure menopausal hot flashes by pharmaceutical company Bionovo, Inc has got the US Food and Drug Administration approval stamp on Thursday. The company focuses on discovery and development of women's health and cancer drugs.
  • Women planning on taking hormone therapy for the treatment of menopausal symptoms should be aware of a possible increased risk for ovarian cancer, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.
  • Follow-up of about 11 years of participants in the Women's Health Initiative finds that among postmenopausal women, use of estrogen plus progestin is associated with an increased incidence of breast cancers that are more advanced, and with a higher risk of deaths attributable to breast cancer, according to a study in the October 20 issue of JAMA.
  • The first research from the Breakthrough Generations Study could lead to a test to predict a woman's reproductive lifespan.
  • Use of estrogen therapy is associated with an increased risk of developing kidney stones in postmenopausal women, according to a report in the October 11 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
  • A new women's health, whole soy germ-based nutritional supplement containing Natural S-equol reduced the frequency of moderate to severe hot flashes and reduced muscle and joint pain in the first study of its kind among postmenopausal U.S. women, according to peer-reviewed data presented as a poster presentation at the North American Menopause Society (NAMS) Annual Meeting.
  • To mark World Menopause Day on 18th October 2010, the International Menopause Society (IMS) is launching new Recommendations for the management of postmenopausal vaginal atrophy, a distressing condition that will affect up to half of women after menopause.
  • As a woman crosses her 40th year, her body starts signaling a decline in her ovarian functions, especially those related to production estrogen production. That means the female body is entering the peri-menopausal phase from which she moves to menopause when her fertility ends, and periods finish off.
  • The United States Food and Drug Administration (FDA) has issued an advisory asking women who use Evamist spray to keep it away from children as possible adverse effects include premature puberty among girls and enlarged breasts for boys.
  • For most women, menopause is a difficult phase in their lives. It is the time when the ovaries cease to function causing a series of changes in the body functions. The menopausal transition starts with varying menstrual cycle length and ends with the final menstrual period.
  • FDA inspection report revealed that Johnson & Johnson's Lancaster, Pa., plant failed to investigate and fix problems when consumers filed complaints that "foreign materials, black or dark specks" were found in medicine bottles.